VS
Vasudevan Sujesh
About Vasudevan Sujesh
Data last updated:
Vasudevan Sujesh is a Director at Hetero Labs Limited (since 2024), Director at Entero Healthcare Solutions Limited (since 2023) and Director at Eris Lifesciences Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma and Machinery and Equipment. The 4 current companies with reported revenue have a combined latest revenue of ₹28,987 Cr; the largest is Hetero Labs Limited at ₹16,537 Cr (FY 2025). Earlier, Vasudevan Sujesh was a Nominee Director at Integrace Private Limited (2018–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hetero Labs Limited U24110TG1989PLC009723 | Director | 22 Feb 2024 | 1989 | ₹16,537 Cr (FY 2025) | Active |
 Entero Healthcare Solutions Limited L74999HR2018PLC072204 | Director | 25 Aug 2023 | 2018 | ₹6,610 Cr (FY 2026) | Active |
 Eris Lifesciences Limited L24232GJ2007PLC049867 | Director | 25 Jul 2022 | 2007 | ₹5,069 Cr (FY 2025) | Active |
 Eris Therapeutics Limited U24230GJ2021PLC123519 | Director | 04 Jul 2025 | 2021 | ₹771 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Integrace Private Limited U51909KA2018PTC115613 | Nominee Director | 28 Sep 2018 | 2018 | ₹246 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vasudevan Sujesh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vasudevan Sujesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vasudevan Sujesh
Vasudevan Sujesh currently holds 4 directorships: Hetero Labs Limited (Director, since 22 Feb 2024, revenue ₹16,537 Cr (FY 2025)); Entero Healthcare Solutions Limited (Director, since 25 Aug 2023, revenue ₹6,610 Cr (FY 2026)); Eris Lifesciences Limited (Director, since 25 Jul 2022, revenue ₹5,069 Cr (FY 2025)); Eris Therapeutics Limited (Director, since 04 Jul 2025, revenue ₹771 Cr (FY 2025)).
Vasudevan Sujesh was first appointed on 28 Sep 2018 as Nominee Director at Integrace Private Limited. The most recent appointment on record is 04 Jul 2025 at Eris Therapeutics Limited.
The 4 current companies of Vasudevan Sujesh that report revenue have a combined latest revenue of ₹28,987 Cr: Hetero Labs Limited ₹16,537 Cr (FY 2025); Entero Healthcare Solutions Limited ₹6,610 Cr (FY 2026); Eris Lifesciences Limited ₹5,069 Cr (FY 2025); Eris Therapeutics Limited ₹771 Cr (FY 2025).
Vasudevan Sujesh held 1 earlier board appointment: Integrace Private Limited (Nominee Director, 28 Sep 2018 to 12 Oct 2021).
The current boards of Vasudevan Sujesh's companies include Attunuri Venkatanarasa Reddy (Hetero Labs Limited), Bandi Vamsikrishna (Hetero Labs Limited), Govindaraju Bhavani (Hetero Labs Limited), Kiran Kumar Manikwar (Hetero Labs Limited), Kshitiz Gadodia (Hetero Labs Limited), Mohana Reddy Chilukuri (Hetero Labs Limited), among others.